Brooklyn Investment Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$255K	Buy	2,029 +1,811	+831%	+$228K	0.03%	497
2025 Q1	$24.1K	Sell	218 -13	-6%	-$1.44K	0.01%	1068
2024 Q4	$31.5K	Buy	231 +115	+99%	+$15.7K	0.01%	648
2024 Q3	$13.4K	Buy	+116	New	+$13.4K	﹤0.01%	727